serum institute news
Latest from serum institute
Adar Poonawalla speaks out on work-life balance: 'Can't go beyond 8-9 hours'
The Serum CEO said that meeting people and building relationships, for charity or networking purposes, is as crucial as office hours.
Updated on Jan 23, 2025 12:43 PM IST
‘Disclosed all rare side effects’: SII clarifies amid vaccine safety row
In India, the Serum Institute of India (SII) said it stopped the manufacturing of additional doses of Covishield since December 2021.
Published on May 08, 2024 07:55 PM IST
Afternoon briefing: Delhi Police's ‘fake msgs’ warning
The shortlist of biggest headlines, recommended stories, and special collection of news items you should check out.
Published on May 02, 2024 01:25 PM IST
Covovax to be available on CoWIN as booster dose soon. Check details
Covovax is likely to be available on the portal in a few days at a price of ₹225 per dose plus applicable GST.
Published on Apr 10, 2023 05:00 PM IST
PTI |
Oxford, Serum initiative: Anti-malaria vaccine’s Phase 3 trials conclude
The R21 malaria vaccine, which is also known as Matrix-M, was designed at the Jenner Institute, University of Oxford, which collaborated with SII in 2020 to manufacture and develop the jab for large-scale supply.
Published on Dec 06, 2022 08:33 AM IST
Soumya Pillai, New Delhi
Monkeypox: As India sees rise in cases, what Adar Poonawalla said about vaccine
India has so far reported eight cases of monkeypox, of which five have been from Kerala and three from Delhi. Of the five patients in Kerala, one succumbed to the disease on July 30, making it India's first monkeypox fatality.
Published on Aug 02, 2022 05:41 PM IST
Written by Sharangee Dutta | Edited by Aniruddha Dhar, New Delhi
SII to manufacture India’s 1st vaccine against cervical cancer after DGCI nod
Cervical cancer is the second most frequent cancer among women in India between the ages of 15 and 44.
Published on Jul 12, 2022 10:48 PM IST
Written by Harshit Sabarwal | Edited by Sohini Goswami, New Delhi
Serum institute seeks government nod to export Covovax to the US
SII manufactures Covovax under a license from the vaccine’s developer, US-based Novavax. The export version of the vaccine is called Nuvaxovid and has been dispatched to New Zealand, Netherlands, Australia and Indonesia, where a total of at least 100 million doses have been sent.
Published on Jul 01, 2022 03:16 AM IST
Rhythma Kaul, New Delhi
DGCI approves Serum Institute of India's Covovax for children aged 7 to 12 years
The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years.
Published on Jun 28, 2022 10:26 PM IST
PTI | , New Delhi
Serum Institute seeks emergency use nod for its rBCG tuberculosis vaccine
India's TB immunisation programme currently offers BCG vaccination at birth or as early as possible till one year of age.
_1648090675572_1648400202069.jpg "World Tuberculosis Day: Expert offers insights on causes and prevention of TB(Unsplash)")
Published on Mar 27, 2022 10:28 PM IST
PTI | , New Delhi
Biocon Biologics, Serum Institute announce strategic alliance
The two companies will enter Service Level Agreements (SLAs) for manufacturing and distribution of the vaccines and antibodies.
Published on Sep 17, 2021 09:54 AM IST
ANI | , Bengaluru
Serum to produce Russia's Sputnik V vaccine from September: RDIF CEO
The CEO of Russian Direct Investment Fund, Kirill Dmitriev, said some other manufactures are also ready to produce this anti-Coronavirus vaccine in India.
Published on Jul 13, 2021 01:55 PM IST
hindustantimes.com | Written by Sohini Goswami, New Delhi
News updates from HT: Another cyclone may form over Bay of Bengal, warns IMD
Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.
Published on May 18, 2021 08:56 PM IST
hindustantimes.com, Hindustan Times, New Delhi
The Taste with Vir Sanghvi: The dream of a modern India is dying
In this week's The Taste, Vir Sanghvi writes, "Such is the despondency over our politicians that many people are now actively considering emigrating to other countries"
Updated on May 06, 2021 01:21 PM IST
Govt's biggest Serum Covid-19 vaccine order covered just 4% of population
Serum is licensed to manufacture Covid shots from AstraZeneca Plc. and Novavax Inc.
Updated on May 03, 2021 03:57 PM IST
Bloomberg |
AstraZeneca serves legal notice to Serum Institute over supply delays
On March 25, Covax announced a major setback in its vaccine rollout because a surge in infections in India caused the Serum Institute of India (SII) to cater to domestic demand, resulting in a delay in global shipments of up to 90 million doses.
Updated on Apr 08, 2021 06:43 AM IST
Agencies | HT Correspondent
SII delays vaccines for private sale in Bangladesh to focus on national campaign
Beximco last week received 5 million of the 30 million doses it had ordered from SII for Bangladesh's immunisation programme that begins next week.
Published on Feb 04, 2021 02:51 PM IST
Reuters |
SII fire accident or sabotage to be known after probe, says Uddhav Thackeray
Five men died in the fire that broke out in a five- storeyed under-construction building in the SII's Manjari premises in Pune on Thursday.
Published on Jan 22, 2021 06:15 PM IST
PTI |
Damage in fire worth 1K crore, Covid vaccine supply not to be impacted: SII CEO
In a statement issued earlier, SII officials had said the fire would impact the production of BCG and Rotavirus vaccines in future.
Updated on Jan 22, 2021 06:22 PM IST
Written by Prashasti Singh, New Delhi
5 dead as fire breaks out at Serum facility
Officials said at least four people were rescued from SII’s Manjari premises in an operation spanning over an hour to bring the fire under control and save those trapped.
Published on Jan 22, 2021 06:46 AM IST
Shalaka Shinde, Pune
'Anguished': PM Modi tweets after fire kills 5 at Pune's Serum Institute
PM Modi prayed for speedy recovery of those who have been injured in the accident.
Updated on Jan 21, 2021 10:58 PM IST
hindustantimes.comHT Correspondent | Edited by Poulomi Ghosh
Vaccine vials land in city, Serum moves 6.4m doses
The first consignment of 264,000 doses of Covishield reached Delhi’s central storage facility at the Rajiv Gandhi Super Specialty Hospital (RGSSH) in the afternoon around high security, according to officials aware of the developments.
Updated on Jan 13, 2021 01:24 AM IST
'When every moment counted', tweets minister Hardeep Puri on vaccine drive
In the vaccination drive scheduled to begin on January 16, the healthcare and frontline workers will be inoculated in the first phase.
Published on Jan 12, 2021 11:02 PM IST
hindustantimes.com | Edited by Amit Chaturvedi
All you need to know about SII vaccine 'Covishield'| 10 points
The first 100 million doses of the vaccine has been provided to the government at the cost of ₹200 per dose, with Serum Institute of India's (SII’s) chief executive officer (CEO) and owner Adar Poonawalla adding that the cost will increase later on.
Updated on Jan 12, 2021 11:16 PM IST
hindustantimes.com | Edited by Harshit Sabarwal, New Delhi
Vaccination drive in India may start in January, says Adar Poonawalla as Serum Institute hopes to get nod by December
Pune’s SII is preparing to manufacture enough vaccines for the government as well as private makers.
Updated on Dec 12, 2020 01:58 PM IST
Hindustan Times, New Delhi | hindustantimes.com | Edited by Poulomi Ghosh
Covid-19 vaccine: Data India seeks from Serum Institute, Bharat Biotech; Canada’s approval to Pfizer vaccine shot | 10 points
Bharat Biotech will have to submit the safety and efficacy data from the ongoing phase 3 clinical trial in the country.
Updated on Dec 10, 2020 08:33 AM IST
Hindustan Times, New Delhi | hindustantimes.com | Edited by Poulomi Ghosh
IAVI, Serum Institute sign pact with Merck to develop coronavirus neutralising antibodies
The antibodies have been co-invented by IAVI and Scripps Research, a non-profit American biomedical research facility, as innovative interventions to rein in the global spread of the Covid-19 pandemic
Updated on Oct 23, 2020 01:13 PM IST
Hindustan Times, New Delhi | HT Correspondent | Edited by Joydeep Sen Gupta
Covid-19: Serum Institute to produce additional 100 million vaccine doses
The initiative brings the total number of vaccine doses to be covered by the partnership to an aggregate of up to 200 million doses, following the initial agreement for up to 100 million doses, which were announced in August
Updated on Sep 29, 2020 03:38 PM IST
Hindustan Times, New Delhi | Rhythma Kaul
Serum Institute says India trials of Covid-19 vaccine ongoing
AstraZeneca said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.
Published on Sep 09, 2020 05:10 PM IST
Bengaluru | Reuters| Posted by Susmita Pakrasi
Serum Institute to begin phase 2 trial of Oxford Covid-19 vaccine candidate today
17 sites have been selected to conduct the phase II/III trials, observer-blind, randomized, controlled study, to check the safety and immune response of the vaccine candidate among healthy Indian adults
Published on Aug 25, 2020 09:57 AM IST
Hindustan Times, New Delhi | Rhythma Kaul
- 1
- 2
- ...